Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assays.

Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assays.
复制标题

DOI:
10.1093/nar/gks623
复制
发表时间:
2012-09-01
影响因子:
14.9
通讯作者:
Frick DN
Frick DN
中科院分区:
生物学2区
文献类型:
--
作者:
Mukherjee S;Hanson AM;Shadrick WR;Ndjomou J;Sweeney NL;Hernandez JJ;Bartczak D;Li K;Frankowski KJ;Heck JA;Arnold LA;Schoenen FJ;Frick DN

文献摘要

参考文献

被引文献

相似文献

用于发现和分析抑制丙型肝炎病毒(HCV)NS 3解旋酶的小分子的典型测定产生很少的命中,并且经常被化合物干扰混淆。寡核苷酸结合试验在这里检查作为一种替代。在比较荧光偏振(FP)、均匀时间分辨荧光(HTRF®; Cisbio)和AlphaScreen®(Perkin Elmer)测定之后,选择基于FP的测定来筛选Sigma的药理学活性化合物文库(LOPAC)中抑制NS 3-DNA复合物形成的化合物。四种LOPAC化合物抑制基于FP的测定:金精三羧酸(ATA)(IC 50 = 1.4 μM)、苏拉明钠盐(IC 50 = 3.6 μM)、NF 023水合物(IC 50 = 6.2 μM)和tyrphostin AG 538(IC 50 = 3.6 μM)。除AG 538外,所有的抑制解旋酶催化的链分离,除NF 023外,所有的抑制亚基因组HCV复制子的复制。使用大肠杆菌单链DNA结合蛋白(SSB)的反筛选显示,没有一种新的HCV解旋酶抑制剂对NS 3 h具有特异性。然而,当基于SSB的测定用于分析另一种非特异性解旋酶抑制剂(染料报春碱的主要组分)的衍生物时,其揭示了一些报春碱衍生物(例如PubChem CID 50930730)对HCV NS 3 h的特异性比类似有效的HCV解旋酶抑制剂高30倍。
Typical assays used to discover and analyze small molecules that inhibit the hepatitis C virus (HCV) NS3 helicase yield few hits and are often confounded by compound interference. Oligonucleotide binding assays are examined here as an alternative. After comparing fluorescence polarization (FP), homogeneous time-resolved fluorescence (HTRF®; Cisbio) and AlphaScreen® (Perkin Elmer) assays, an FP-based assay was chosen to screen Sigma’s Library of Pharmacologically Active Compounds (LOPAC) for compounds that inhibit NS3-DNA complex formation. Four LOPAC compounds inhibited the FP-based assay: aurintricarboxylic acid (ATA) (IC50 = 1.4 μM), suramin sodium salt (IC50 = 3.6 μM), NF 023 hydrate (IC50 = 6.2 μM) and tyrphostin AG 538 (IC50 = 3.6 μM). All but AG 538 inhibited helicase-catalyzed strand separation, and all but NF 023 inhibited replication of subgenomic HCV replicons. A counterscreen using Escherichia coli single-stranded DNA binding protein (SSB) revealed that none of the new HCV helicase inhibitors were specific for NS3h. However, when the SSB-based assay was used to analyze derivatives of another non-specific helicase inhibitor, the main component of the dye primuline, it revealed that some primuline derivatives (e.g. PubChem CID50930730) are up to 30-fold more specific for HCV NS3h than similarly potent HCV helicase inhibitors.
DOI: 10.1371/journal.pone.0008350
发表时间: 2009-12-17
期刊: PloS one
影响因子: 3.7
作者:
Hashem AM;Flaman AS;Farnsworth A;Brown EG;Van Domselaar G;He R;Li X
通讯作者: Li X
DOI: 10.1038/nrd1853
发表时间: 2005-10
期刊: Nature reviews. Drug discovery
影响因子: --
作者:
Kwong AD;Rao BG;Jeang KT
通讯作者: Jeang KT
DOI: 10.1016/s0969-2126(98)00010-0
发表时间: 1998-01-15
期刊: STRUCTURE
影响因子: 5.7
作者:
Kim, JL;Morgenstern, KA;Caron, PR
通讯作者: Caron, PR
DOI: 10.1016/j.bmcl.2010.09.002
发表时间: 2011-05-01
影响因子: 2.7
作者:
Gemma, Sandra;Butini, Stefania;Maga, Giovanni
通讯作者: Maga, Giovanni
DOI: 10.3851/imp1286
发表时间: 2009-09-25
影响因子: --
作者:
Chen, Ye;Bopda-Waffo, Alain;Kaushik-Basu, Neerja
通讯作者: Kaushik-Basu, Neerja